Clinical Trial Update: High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether high-dose rosuvastatin given before primary PCI improves outcomes in patients with ST-elevation myocardial in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute | Conditions: ST Elevation (STEMI) Myocardial Infarction | Phase 2 | Status: ACTIVE_NOT_RECRUITING